Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05008055
Title Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL)
Acronym CAPITAL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP | DNK | CAN

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Los Angeles California 90095 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Victoria British Columbia V8R 6V5 Canada Details
Research Site Aarhus N DK8200 Denmark Details
Research Site Poitiers 86021 France Details
Research Site Villejuif Cedex 94805 France Details
Research Site Busan 49241 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Seoul 3722 Korea, Republic of Details
Research Site Badalona 08003 Spain Details
Research Site Barcelona 8035 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
Research Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field